Provention Wins FDA Approval for First Drug to Delay Type 1 Diabetes Progression
Type 1 diabetes patients now have a new therapeutic option for the autoimmune disorder. Provention Bio drug Tzield has received FDA approval for delaying the onset of the most severe stage of this chronic disease.